Verkkothe new project, bespoke gene therapy consortium, hopes its work on 8 rare diseases will set the standard and framework to help thousands of.
Verkkogrifols will explore new applications and use cases for data and ai in the biopharma sector.
Verkkoa review of the current landscape for rare diseases, which affect 300 million people worldwide and have high genetic and diagnostic complexity.
Verkkothrough its investee alkahest, grifols continues to drive new knowledge of the plasma proteome to determine plasma proteins associated with aging, a discovery.
There are three main resources we highlight for nonprofits:
Verkkobecoming a critical user of media is a premise for citizenship in contemporary times.
© 2025 Jhu Innovations. All rights reserved.
















